GlobeNewswire09 Nov 2021 Inagene Diagnostics Inc.’s CEO featured alongside global expert advocates highlighting pharmacogenomic (gene-drug compatibility) testing as a game-changing innovation to safeguard the health of Canadians
GlobeNewswire09 Nov 2021 Inagene Diagnostics Inc. and Granville Biomedical Inc. team up to provide locally-produced pharmacogenetic testing kits to Canadians
The Globe and Mail09 Nov 2021 Pharmacogenetic testing uses DNA to predict patients’ responses to medications
Financial Post09 Nov 2021 September's International Pain Awareness Month marks critical moment to leverage more effective methods of treating chronic pain…
Financial Post09 Nov 2021 Canada's surgery backlog could lead to wave of new chronic pain and opioid dependencies According to Inagene Diagnostics Inc., genetic testing can help mitigate the risk of chronic pain and reliance on medications
Financial Post09 Nov 2021 Canadians living with mental health conditions stand to save over $57 billion with use of pharmacogenetic testing…
